KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer

Alam, Hunain, Tang, Ming, Maitituoheti, Mayinuer, Dhar, Shilpa S., Kumar, Manish, Han, Chae Young, Ambati, Chandrashekar R., Amin, Samir B. +11 more·2020·Cancer Cell
DOI 10.1016/j.ccell.2020.03.005

Cited by (255)

Items 201–255 of 255

  1. Integrated analysis of multi-omics data to establish a hypoxia-related prognostic model in osteosarcoma
    Ye Tong, Xiaoqing Zhang, Ye Zhou · 2022 · Research Square
  2. ACAT2 may be a novel predictive biomarker and treated target in lung adenocarcinoma
    Zhongchao Wang, ZHUGEN CAO, Zhaoxia Dai · 2023
  3. Data from Loss of MLL Induces Epigenetic Dysregulation of Rasgrf1 to Attenuate Kras-Driven Lung Tumorigenesis
    Ling-Yu Zhu, Jun-Bo Yuan, Li Zhang, Chun-Xiao He, Xiao Lin, Bin Xu, Guang‐Hui Jin · 2023
  4. Data from Loss of MLL Induces Epigenetic Dysregulation of Rasgrf1 to Attenuate Kras-Driven Lung Tumorigenesis
    Ling-Yu Zhu, Jun-Bo Yuan, Li Zhang, Chun-Xiao He, Xiao Lin, Bin Xu, Guang‐Hui Jin · 2023
  5. Necrosis-associated long noncoding RNA for predicting prognosis in hepatocellular carcinoma
    Xin Wang, Jun Yang, Zhenglai Ma, Zhongjie Hu · 2023 · Research Square
  6. Epigenetic therapy in lung cancer
    Michael R. Conroy, Áine O’Connor, Maeve Bailey‐Whyte, Catríona M. Dowling · 2023 · Elsevier eBooks
  7. Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of lysine demethylation and oxidative phosphorylation
    Shilpa S. Dhar, Calena J. Brown, Ali Rizvi, Lauren Reed, Sivareddy Kotla, Constantin Zod, Janak Abraham, Jun‐ichi Abe, Veena Rajaram, Kaifu Chen et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  8. Mapping in silico genetic networks of the KMT2D tumour suppressor gene to uncover novel functional associations and cancer cell vulnerabilities
    Yuka Takemon, Erin Pleasance, Alessia Gagliardi, Christopher S. Hughes, Veronika Csizmók, Kathleen Wee, Diane L.N. Trinh, Ryan D. Huff, Andrew J. J. Mungall, Richard A. Moore et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  9. MAPK dependent regulation of FBXW7 phosphodegrons
    Neha Singh · 2023 · Eötvös Loránd Tudományegyetem
  10. Additional file 8 of A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks
    Chongze Yuan, Haojie Chen, Shiqi Tu, Hsin‐Yi Huang, Yunjian Pan, Xiuqi Gui, Muyu Kuang, Xuxia Shen, Qiang Zheng, Yang Zhang et al. · 2021 · Figshare
  11. Additional file 3 of A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks
    Chongze Yuan, Haojie Chen, Shiqi Tu, Hsin‐Yi Huang, Yunjian Pan, Xiuqi Gui, Muyu Kuang, Xuxia Shen, Qiang Zheng, Yang Zhang et al. · 2021 · Figshare
  12. Additional file 2 of A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks
    Chongze Yuan, Haojie Chen, Shiqi Tu, Hsin‐Yi Huang, Yunjian Pan, Xiuqi Gui, Muyu Kuang, Xuxia Shen, Qiang Zheng, Yang Zhang et al. · 2021 · Figshare
  13. Additional file 10 of A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks
    Chongze Yuan, Haojie Chen, Shiqi Tu, Hsin‐Yi Huang, Yunjian Pan, Xiuqi Gui, Muyu Kuang, Xuxia Shen, Qiang Zheng, Yang Zhang et al. · 2021 · Figshare
  14. Additional file 9 of A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks
    Chongze Yuan, Haojie Chen, Shiqi Tu, Hsin‐Yi Huang, Yunjian Pan, Xiuqi Gui, Muyu Kuang, Xuxia Shen, Qiang Zheng, Yang Zhang et al. · 2021 · Figshare
  15. Additional file 7 of A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks
    Chongze Yuan, Haojie Chen, Shiqi Tu, Hsin‐Yi Huang, Yunjian Pan, Xiuqi Gui, Muyu Kuang, Xuxia Shen, Qiang Zheng, Yang Zhang et al. · 2021 · Figshare
  16. Additional file 4 of A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks
    Chongze Yuan, Haojie Chen, Shiqi Tu, Hsin‐Yi Huang, Yunjian Pan, Xiuqi Gui, Muyu Kuang, Xuxia Shen, Qiang Zheng, Yang Zhang et al. · 2021 · Figshare
  17. Additional file 5 of A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks
    Chongze Yuan, Haojie Chen, Shiqi Tu, Hsin‐Yi Huang, Yunjian Pan, Xiuqi Gui, Muyu Kuang, Xuxia Shen, Qiang Zheng, Yang Zhang et al. · 2021 · Figshare
  18. Additional file 11 of A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks
    Chongze Yuan, Haojie Chen, Shiqi Tu, Hsin‐Yi Huang, Yunjian Pan, Xiuqi Gui, Muyu Kuang, Xuxia Shen, Qiang Zheng, Yang Zhang et al. · 2021 · Figshare
  19. Additional file 6 of A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks
    Chongze Yuan, Haojie Chen, Shiqi Tu, Hsin‐Yi Huang, Yunjian Pan, Xiuqi Gui, Muyu Kuang, Xuxia Shen, Qiang Zheng, Yang Zhang et al. · 2021 · Figshare
  20. Whole Genome Sequencing and single-cell transcriptomics identify KMT2D as a potential new driver for pituitary adenomas
    Maxime Brunner, Jenny Meylan-Merlini, Maude Muriset, Sergey Oreshkov, Andrea Messina, Mahmoud Messerer, Roy Thomas Daniel, Ekkehard Hewer, Jean‐Philippe Brouland, Federico Andrea Santoni · 2024 · medRxiv
  21. KMT2D Induces M1 Macrophage Polarization to Repress Non-small Cell Lung Cancer Progression via Transcription Activation of ITGAL
    Wentao Wang, Jie Yang, Peng-Fei Jiang · 2025 · Iranian journal of pharmaceutical research
  22. Detailed in vivo analysis of the non-canonical RNA binding activity of histone lysine methyltransferases KMT2D and SETD1A
    Harem, Sabr Muhamad Amin · 2024 · Eötvös Loránd Tudományegyetem
  23. Role of the period family in mediating the interplay between circadian disruption and cancer (Review)
    Pengfei Gu, Wenjian Xu, Xiaorui Fan, Qiang Gao, Yukun Wei, Haojie Zhang, Yuzhen Cui, Yong Pyo Han · 2025 · Oncology Letters
  24. Temporal control of sgRNA library activation unlocks large-scale in vivo CRISPR screens
    Silvia Fenoglio, Yi Yu, James Tepper, Lauren Grove, Alborz Bejnood, Samuel R. Meier, Ashley H Choi, Hsin‐Jung Wu, Annabel Devault, Shangtao Liu et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  25. Ultrasound-guided liver biopsy of focal lesions: comparison between direct and coaxial techniques
    Rafael Varela Ponte, Enrique Flores, Nieves Martínez Lago, José Martín Carreira · 2025 · Revista Española de Enfermedades Digestivas
  26. Genetic composition and evolutionary trajectories of brain metastasis in non-small-cell lung cancer
    Marcin Nicoś, Natalia Galant, Anna Kowalczyk, Rafał Pęksa, Bożena Jarosz, Monika Żuk, Bartosz Wasąg, Renata Duchnowska, Paweł Krawczyk, Jacek Jassem et al. · 2025 · Lung Cancer
  27. Activation of WDHD1 by DNA demethylases promotes MINPP1 transcription and glycolysis in lung adenocarcinoma progression
    Guibin Zhao, Haiyan Liu, Daolin Ji, Xiao Ma, Gang Tan · 2025 · Respiratory Research
  28. Additional file 12 of A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks
    Chongze Yuan, Chen, Haojie, Shiqi Tu, Huang, Hsin-Yi, Pan, Yunjian, Xiuqi Gui, Muyu Kuang, Shen, Xuxia, Zheng, Qiang, Zhang, Yang et al. · 2021 · Figshare
  29. Additional file 1 of Histone methyltransferase KMT2D cooperates with MEF2A to promote the stem-like properties of oral squamous cell carcinoma
    Wang, Xinmiao, Li, Rui, Luping Wu, Chen, Yang, Liu, Shaopeng, Zhao, Hui, Wang, Yifan, Wang, Lin, Zhe Shao · 2022 · Figshare
  30. Additional file 2 of Identification of novel miRNAs potentially involved in the pathogenesis of adult T-cell leukemia/lymphoma using WGCNA followed by RT-qPCR test of hub genes
    Ali Shayeghpour, Forghani-Ramandi, Mohammad-Moien, Setayesh Solouki, Amin Hosseini, Parastoo Hosseini, Sara Khodayar, Mahsa Hasani, Aghajanian, Sepehr, Zeinab Siami, Mohadeseh Zarei Ghobadi et al. · 2024 · Figshare
  31. Additional file 1 of Identification of novel miRNAs potentially involved in the pathogenesis of adult T-cell leukemia/lymphoma using WGCNA followed by RT-qPCR test of hub genes
    Ali Shayeghpour, Forghani-Ramandi, Mohammad-Moien, Setayesh Solouki, Amin Hosseini, Parastoo Hosseini, Sara Khodayar, Mahsa Hasani, Aghajanian, Sepehr, Zeinab Siami, Mohadeseh Zarei Ghobadi et al. · 2024 · Figshare
  32. Additional file 1 of A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks
    Chongze Yuan, Chen, Haojie, Shiqi Tu, Huang, Hsin-Yi, Pan, Yunjian, Xiuqi Gui, Muyu Kuang, Shen, Xuxia, Zheng, Qiang, Zhang, Yang et al. · 2021 · Figshare
  33. Additional file 2 of Histone methyltransferase KMT2D cooperates with MEF2A to promote the stem-like properties of oral squamous cell carcinoma
    Wang, Xinmiao, Li, Rui, Luping Wu, Chen, Yang, Liu, Shaopeng, Zhao, Hui, Wang, Yifan, Wang, Lin, Zhe Shao · 2022 · Figshare
  34. A tryptophan-phenylalanine binding motif for the histone methyltransferases MLL4 and MLL3
    Soumi Biswas, Zohreh Tavaf, Caroline Benz, Moustafa Khalil, Dustin C. Becht, Leandro Simonetti, M. Andrés Blanco, El Bachir Affar, Ylva Ivarsson, Tatiana G. Kutateladze · 2026 · Journal of Biological Chemistry
  35. Pathway-Centric Identification of Candidate Genes in Lung Adenocarcinoma Using TCGA Dataset
    Shrabon Rani Nath, Sheuli Sultana, Durjoy Mondal, Wahia Tasnim, Humayan Kabir Rana · 2025 · International Conference on Sustainable Technologies for Industry 5.0 (STI)
  36. Stress-Induced ADGRL4 Orchestrates Tumor Progression and Metastasis by Inhibiting YAP1 Signaling and Activating Angiogenesis
    Yalan Wu, Mengdi Cao, Huixia Liu, Junfeng Zhang, Yanxue Mei, Guo Li, Fujun Dai, Xiaolong Tang · 2026 · Cancer Research
  37. Analyses of KDM4 Family for Prognostic Values and Immune Infiltration in Patients with Hepatocellular Carcinoma
    Ting-Yuan Feng, Kuo‐Feng Hsu, Guo‐Shiou Liao, Zhi‐Jie Hong · 2026 · Journal of Medical Sciences
  38. Histone methylation activity of KMT2D is required for proliferative control of the developing lung
    Aalekh S. Mehta, Guojia Xie, Frances A. High, Patricia K. Donahoe, Samuel P. Rowbotham · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Chromatin regulator expression patterns predict prognosis and guide neoadjuvant therapy in esophageal squamous cell carcinoma
    Jia Liu, Wenyan Sun, Jiangcong Ma, Chengxiang Han, Qinghao Zhu, Yang Li, Shuwen Zheng, Xin Sun, Yong Huang, Qiong Wu et al. · 2026 · Fundamental Research
  40. Etude des résistances aux inhibiteurs d’ALK dans les LAGC ALK+
    Damien Vasseur · 2023
  41. The Histone‐Lysine N‐Methyltransferase (KMT2) Family in Health and Disease
    Qiu Wang, Zunjie Bo, Ya Zhang, Yun Chen, Z. Wang, Shuangmei Tong, Ajing Xu, George Zhang, Yan Liu · 2026 · MedComm
  42. Understanding super enhancers in genome architecture and their roles in livestock breeding
    Jie Cheng, Xiukai Cao, Kai Yang, Yuee Gao, Zexuan Hong, Xudong Tang, Ping Qian, Bizhi Huang · 2026 · BMC Genomics
  43. Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non–Small Cell Lung Cancer
    Neil Ari Wijetunga, Nikhil P. Mankuzhy, Emily S. Lebow, Lillian A. Boe, Luke Pike, Adam Jacob Schoenfeld, Narek Shaverdian, Tafadzwa Lawrence Chaunzwa, D. Jones, Jamie E. Chaft et al. · 2026 · JCO Precision Oncology
  44. SerpinB7 promotes c-Myc-mediated glycolysis by interacting with ANXA2 to facilitate the progression of non-small cell lung cancer
    Fulei Zhao, Fanlian Zeng, Pei Zhou, Huaping Zheng, Yue Hu, Jie Tang, Yawen Hu, Guolin Li, Yuting Feng, Xiaoyan Wang et al. · 2026 · Molecular Cancer
  45. Targeting the KMT2D-driven Enhancer–Immune–Metabolic axis in HNSCC: Reconciling the paradox for precision therapy
    Kexin Wang, Haijun Lu, Nian Deng, Yueqin Tao, Xiaochen Yang, Mujie Yuan, Longhua Gao, Shuai Jiang, Wei Shang, Jing Deng et al. · 2026 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  46. The role of flavonoids in epigenetic regulation—a mechanism behind their anti-cancer potential
    Dharambir Kashyap, Riya Sharma, Vimal Singh Munda, Vivek Kumar Garg, Sheetal Thakur, Deepti Sharma, Charles Odilichukwu R. Okpala, Vandana Dhiman · 2026 · Elsevier eBooks
  47. Luteolin and its derivatives: modulation of epithelial-mesenchymal transition in fibrosis and cancer
    Guodong Zang, Ying Liu, Xingyu Mu, Yingju Li, Rui Fan · 2026 · Frontiers in Pharmacology
  48. UDP-glucuronate decarboxylase 1 promotes tumor immune evasion by accelerating KMT2D loss in hepatocellular carcinoma
    Jiwei Zhang, Y Li, Jiafeng Chen, Fen Ma, Ben Feng, Shiling ZHOU, Yongchao Cai, Sun Y, Zheng Gao, 董恩伏 et al. · 2026 · Journal for ImmunoTherapy of Cancer
  49. The MAPK/ATF3/ASNS axis drives amino acid metabolic reprogramming to promote NSCLC survival under glucose deprivation
    Fuzhi Yang, Hao Qin, Xuelin Zhang, Yun Zhao, Shuai Jiang, X D Chen, Z J Li, Jing Wang, Dongfang Tang, Wen Gao et al. · 2026 · Journal of Translational Medicine
  50. Translational perspectives on immunotherapy targets, germline syndromes, and novel fusions
    Prabudh Goel · 2026 · The Oncologist
  51. Kmt2c and Kmt2d histone methyltransferase deficiencies compromise macrophage function
    Burcu Al, Yerin Jung, Yubell Alvarez, Alice Scarpa, Arslan Hamid, Younghoon Jang, Kai Ge, Elena De Domenico, Marc D. Beyer, Heike Weighardt et al. · 2026 · Journal of Leukocyte Biology
  52. Dysregulated KMT2D mutant targeting immunogenic rewiring to overcome epigenetic entropy promotes follicular lymphomagenesis
    Yuqian Zhu, Jingwei Yao, Yuelong Jiang, Qian Lai, Qinwei Chen, Jingxing Zhang, Manman Deng, Zhijuan Lin, Yiming Luo, Zhifeng Li et al. · 2026 · Experimental Hematology and Oncology
  53. KMT2D, a key factor in driving cellular transformation and influencing therapeutic response across cancer lineages
    Priyanka Sahu, Yeuan Ting Lee, Angeliki Karatza, Yi Jer Tan, Hsin-Yi Huang, Jonathan So, Kwok‐Kin Wong · 2026 · Critical Reviews in Oncology/Hematology
  54. Trp53 heterozygosity defines novel states impacting tumor plasticity and progression in Kras-initiated non-small cell lung cancer
    V Mitheera, Abhishek Koladiya, Aatish Thennavan, Xiaojie Yu, Guillermina Lozano · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Epigenetics in development, disease, and therapy: from mechanisms to clinical interventions
    Yixuan Ren, Lei Yang, Boyi Fei, Rong Guo, Junran Huang, Zhenghao Xu, Ruoran Wang, Pinqi Zhang, Dandan Cao, Pan Chen et al. · 2026 · Science China Life Sciences